Primary Site >> Pancreatic Cancer

Gene >> CHGA

Journal: Zhonghua Bing Li Xue Za Zhi. 1999 Oct;28(5):337-9.
Title: [A clinicopathological study of pancreatoblastoma].
Author: He, L|Li, P|Liu, S|Wang, L|Liu, N|Du, X
PMID: 11869544
Journal: J Clin Endocrinol Metab. 1999 Aug;84(8):2712-7.
Title: Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.
Author: Granberg, D|Stridsberg, M|Seensalu, R|Eriksson, B|Lundqvist, G|Oberg, K|Skogseid, B
PMID: 10443665
Journal: Mod Pathol. 2000 Feb;13(2):140-6.
Title: Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors.
Author: Kimura, N|Pilichowska, M|Okamoto, H|Kimura, I|Aunis, D
PMID: 10697270
Journal: Chin Med J (Engl). 2000 Jan;113(1):70-4.
Title: Neuroendocrine differentiation in ovarian mucinous tumors.
Author: Jiang, C|Tan, Y|Li, E|Zhang, D
PMID: 11775215
Journal: Endocr Pathol. 2001 Summer;12(2):147-55.
Title: Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas.
Author: Pilichowska, M|Kimura, N|Schindler, M|Kobari, M
PMID: 11579680
Journal: Endokrynol Pol. 2005 May-Jun;56(3):302-7.
Title: [Diagnostic and therapeutic difficulties in MEN 1 syndrome].
Author: Krassowski, Janusz
PMID: 16350723
Journal: Arch Gerontol Geriatr. 2009 Mar-Apr;48(2):213-7.
Title: Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer.
Author: Malaguarnera, Michele|Cristaldi, Erika|Cammalleri, Lisa|Colonna, Valentina|Lipari, Helga|Capici, Alessandra|Cavallaro, Andrea|Beretta, Massimiliano|Alessandria, Innocenza|Luca, Salvatore|Motta, Massimo
PMID: 18329114
Journal: Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Dec 18;41(6):652-6.
Title: [Clinical pathological analysis in 14 cases of pancreatic solid-pseudopapillary tumors].
Author: Mei, Fang|DU, Juan|Ma, Xiao-long
PMID: 20019775
Journal: J Clin Oncol. 2010 Jan 1;28(1):69-76.
Title: Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.
Author: Yao, James C|Lombard-Bohas, Catherine|Baudin, Eric|Kvols, Larry K|Rougier, Philippe|Ruszniewski, Philippe|Hoosen, Sakina|St Peter, Jessica|Haas, Tomas|Lebwohl, David|Van Cutsem, Eric|Kulke, Matthew H|Hobday, Timothy J|O'Dorisio, Thomas M|Shah, Manisha H|C
PMID: 19933912
Journal: Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):642-6.
Title: Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia.
Author: Gori, Giovanni|Spinelli, Giacomo|Spinelli, Claudio|Tuccori, Marco|Blandizzi, Corrado|Del Tacca, Mario
PMID: 20938461
Journal: Med Oncol. 2011 Dec;28(4):1027-31.
Title: Preoperative diagnosis of nonfunctioning pancreatic neuroendocrine tumors.
Author: Li, Ji|Luo, Guopei|Fu, Deliang|Jin, Chen|Hao, Sijie|Yang, Feng|Wang, Xiaoyi|Yao, Lie|Ni, Quanxing
PMID: 20623205
Journal: In Vivo. 2011 Nov-Dec;25(6):1027-9.
Title: Usefulness of chromogranin A, neuron-specific enolase and 5-hydroxyindolacetic acid measurements in patients with malignant carcinoids.
Author: Manfe, Anna Zaira|Norberto, Lorenzo|Marchesini, Marco|Lumachi, Franco
PMID: 22021701
Journal: Horm Metab Res. 2011 Nov;43(12):832-7.
Title: Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
Author: Lindholm, D P|Oberg, K
PMID: 22009449
Journal: Endocr Relat Cancer. 2011 Jul 1;18(4):439-50.
Title: Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors.
Author: Mole, Daniela|Gagliano, Teresa|Gentilin, Erica|Tagliati, Federico|Pasquali, Claudio|Ambrosio, Maria Rosaria|Pansini, Giancarlo|Degli Uberti, Ettore C|Zatelli, Maria Chiara
PMID: 21606156
Journal: Zhonghua Nei Ke Za Zhi. 2011 Feb;50(2):124-7.
Title: [The diagnostic value of plasma chromogranin A in neuroendocrine tumors].
Author: Yang, Xiao-Ou|Li, Jing-Nan|Qian, Jia-Ming|Yang, Hong|Chen, Qiang|Lu, Lin
PMID: 21418832
Journal: Zhonghua Zhong Liu Za Zhi. 2014 Apr;36(4):287-93.
Title: [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Author: Yao, Wenqing|Wang, Weiya|Li, Gandi
PMID: 24989916
Journal: Int J Surg. 2016 May;29:108-17.
Title: A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.
Author: Ye, Liangtao|Ye, Huilin|Zhou, Quanbo|Li, Zhihua|Lin, Qing|Tan, Langping|Gao, Wenchao|Fu, Zhiqiang|Zheng, Shangyou|Chen, Rufu
PMID: 27000717
Journal: Front Med. 2016 Dec;10(4):444-450.
Title: Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.
Author: Cheng, Yugang|Zhan, Hanxiang|Wang, Lei|Xu, Jianwei|Zhang, Guangyong|Zhang, Zongli|Hu, Sanyuan
PMID: 27757796
Journal: J Surg Res. 2017 May 1;211:206-214.
Title: Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors
Author: Mirkin, Katelin A|Hollenbeak, Christopher S|Wong, Joyce
PMID: 28501118
Journal: Endocr Connect. 2018 Feb;7(2):355-363.
Title: Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology.
Author: Han, Xu|Xu, Xuefeng|Ma, Hongyun|Ji, Yuan|Wang, Dansong|Kuang, Tiantao|Wu, Wenchuan|Song, Bin|Li, Gang|Jin, Gang|Lou, Wenhui
PMID: 29472376
Journal: HPB (Oxford). 2018 Oct 23. pii: S1365-182X(18)34466-6.
Title: Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors.
Author: Pulvirenti, Alessandra|Rao, Deepthi|Mcintyre, Caitlin A|Gonen, Mithat|Tang, Laura H|Klimstra, David S|Fleisher, Martin|Ramanathan, Lakshmi V|Reidy-Lagunes, Diane|Allen, Peter J
PMID: 30366884